Related Experiment Video
Updated: Mar 16, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.3K
Atrial Fibrillation, Cognitive Decline And Dementia
Alvaro Alonso1, Antonio P Arenas de Larriva2
1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
European Cardiology
|August 23, 2016
Summary
Atrial fibrillation (AF) increases the risk of cognitive decline and dementia. Managing AF and cardiovascular health may help reduce these risks.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia.
- Emerging evidence links AF to cognitive decline and dementia.
- Understanding this association is crucial for public health.
Purpose of the Study:
- To review epidemiological data on AF and cognitive outcomes.
- To explore potential mechanisms linking AF to cognitive impairment.
- To examine the effect of AF treatments on cognitive decline.
Main Methods:
- Systematic review of community-based observational studies.
- Analysis of epidemiological observations.
- Synthesis of mechanistic insights and treatment impacts.
Main Results:
- Consistent association between AF and higher rates of cognitive decline.
- Increased risk of dementia in individuals with AF.
- Mechanisms include clinical stroke, silent infarcts, microbleeds, and hypoperfusion.
Conclusions:
- AF is a significant risk factor for cognitive decline and dementia.
- Oral anticoagulation and cardiovascular risk management are key.
- These interventions may mitigate AF's impact on cognitive health.
Related Concept Videos
01:30Dementia
658
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
658
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:30Cognitive Development During Adulthood
1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:30Coronary Artery Disease III: Clinical Manifestations
510
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
510
01:26Heart Failure III: Clinical Manifestations
781
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
781